CF Industries Holdings, Inc. (CF) Stock Forecast
Data as of Jun 16, 2026Basic Materials · Current price $105.56 (-1.19%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 8, 2026 | Vincent Andrews | Morgan Stanley | $135.00 | +27.9% |
| Feb 24, 2026 | Joshua Spector | UBS | $97.00 | -8.1% |
| Feb 19, 2026 | Edlain Rodriguez | Mizuho Securities | $95.00 | -10.0% |
| Jan 12, 2026 | Joshua Spector | UBS | $86.00 | -18.5% |
| Dec 2, 2025 | Hamir Patel | CIBC | $87.00 | -17.6% |
| Nov 10, 2025 | Ben Isaacson | Scotiabank | $90.00 | -14.7% |
| Oct 9, 2025 | Edlain Rodriguez | Mizuho Securities | $100.00 | -5.3% |
| Oct 6, 2025 | Joshua Spector | UBS | $96.00 | -9.1% |
| Jul 14, 2025 | Andrew Wong | RBC Capital | $100.00 | -5.3% |
| Jun 26, 2025 | Vincent Andrews | Morgan Stanley | $95.00 | -10.0% |
| Apr 22, 2025 | Benjamin Theurer | Barclays | $87.00 | -17.6% |
| Nov 8, 2024 | Charles Neivert | Piper Sandler | $79.00 | -25.2% |
| Oct 22, 2024 | Charles Neivert | Piper Sandler | $77.00 | -27.1% |
| Oct 18, 2024 | Mazahir Mammadli | Redburn Partners | $77.00 | -27.1% |
| Oct 16, 2024 | Steve Byrne | Bank of America Securities | $83.00 | -21.4% |
| Oct 9, 2024 | Edlain Rodriguez | Mizuho Securities | $93.00 | -11.9% |
| Aug 16, 2024 | Benjamin Theurer | Barclays | $90.00 | -14.7% |
| Aug 9, 2024 | Joel Jackson | BMO Capital | $100.00 | -5.3% |
| Jul 23, 2024 | Benjamin Theurer | Barclays | $80.00 | -24.2% |
| Jun 11, 2024 | Charles Neivert | Piper Sandler | $73.00 | -30.8% |
Top Analysts Covering CF
CF vs Sector & Market
| Metric | CF | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.88 | 2.36 | 2.40 |
| Analyst Count | 26 | 7 | 19 |
| Target Upside | +2.4% | +90.7% | +17.1% |
| P/E Ratio | 9.48 | -10.25 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $6.86B | $7.58B | $9.26B | 12 |
| 2027-03-31 | $1.85B | $2.11B | $2.56B | 2 |
| 2027-06-30 | $1.66B | $1.89B | $2.28B | 2 |
| 2027-09-30 | $1.28B | $1.46B | $1.76B | 2 |
| 2027-12-31 | $1.44B | $1.65B | $1.99B | 2 |
| 2028-03-31 | $1.79B | $2.04B | $2.47B | 1 |
| 2028-06-30 | $1.51B | $1.72B | $2.09B | 1 |
| 2028-09-30 | $1.10B | $1.25B | $1.52B | 1 |
| 2028-12-31 | $1.30B | $1.48B | $1.80B | 1 |
| 2029-12-31 | $5.46B | $6.27B | $7.65B | 5 |
| 2030-12-31 | $5.58B | $6.40B | $7.81B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $9.51 | $12.62 | $19.68 | 6 |
| 2027-03-31 | $2.86 | $3.40 | $4.33 | 2 |
| 2027-06-30 | $2.85 | $3.39 | $4.32 | 1 |
| 2027-09-30 | $1.63 | $1.93 | $2.47 | 1 |
| 2027-12-31 | $1.78 | $2.11 | $2.69 | 2 |
| 2028-03-31 | $3.46 | $4.12 | $5.25 | 3 |
| 2028-06-30 | $1.80 | $2.13 | $2.72 | 2 |
| 2028-09-30 | $0.06 | $0.07 | $0.09 | 2 |
| 2028-12-31 | $0.58 | $0.69 | $0.88 | 3 |
| 2029-12-31 | $5.96 | $7.15 | $9.20 | 1 |
| 2030-12-31 | $6.14 | $7.37 | $9.48 | 1 |
Frequently Asked Questions
What is the analyst consensus for CF?
The consensus among 26 analysts covering CF Industries Holdings, Inc. (CF) is Hold with an average price target of $97.13.
What is the highest price target for CF?
The highest price target for CF is $135.00, set by Vincent Andrews at Morgan Stanley on 2026-04-08.
What is the lowest price target for CF?
The lowest price target for CF is $59.50, set by Santhosh Seshadri at HSBC on 2021-08-20.
How many analysts cover CF?
26 analysts have issued ratings for CF Industries Holdings, Inc. in the past 12 months.
Is CF a buy or sell right now?
Based on 26 analyst ratings, CF has a consensus rating of Hold (2.88/5) with a +2.4% upside to the consensus target of $97.13.
What are the earnings estimates for CF?
Analysts estimate CF will report EPS of $12.62 for the period ending 2026-12-31, with revenue estimated at $7.58B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.